Skip to main content
Equibles
GALT logo

GALT · Galectin Therapeutics Inc · Suppliers & Customers

Track GALT — free

Use GALT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GALT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.19 -0.19 (-5.62%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of 12 months from the issuance date of these financial statements.”
View the 10-Q filed Aug 14, 2026
Market Cap
$321.71M
Shares
100.85M
Volume · Oct 23 195.22K Avg daily vol (3M) 303.16K

Supply Chain

Customers, suppliers, competitors and partners, private companies included: the ones GALT names, and the companies that name GALT.

Read supply chains in your AI or your code through MCP and the API →
Diagram Table Overlap
Pro

See who GALT sells to, buys from and competes with

  • 0 suppliers
  • 0 customers
  • 1 competitor

Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.

View plans
Key facts CIK 1133416 CUSIP 363225202 13F (30d) 15 filings 15 filers Visit website Investor relations